EUVIMEDEUVIMED entdecken
Crossref

Coupling between GPR143 and dopamine D2 receptor is required for selective potentiation of dopamine D2 receptor function by L‐3,4‐dihydroxyphenylalanine in the dorsal striatum

Daiki Masukawa iD, Satoshi Kitamura, Rei Tajika, Hiraku Uchimura, Masami Arai, Yuuki Takada, Tetsu Arisawa, Momoyo Otaki, Kaori Kanai, Kenta Kobayashi, Tomoyuki Miyazaki, Yoshio Goshima iD

Journal of Neurochemistry · 2023-04 · 165 (2) · 177-195

DOI: 10.1111/jnc.15789 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurochemistry, online erschienen am 09.03.2023. Verfasst von Daiki Masukawa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmacology and Neurobiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan. Hauptthemen laut MEDLINE: Levodopa, Parkinson Disease, Receptors, Dopamine D2. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Takeda Science Foundation, Uehara Memorial Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dopamine (DA) is involved in neurological and physiological functions such as motor control. L‐3,4‐dihydroxyphenylalanine (L‐DOPA), a precursor of DA, is conventionally believed to be an inert amino acid precursor of DA, and its major therapeutic effects in Parkinson's disease (PD) are mediated through its conversion to DA. On the contrary, accumulating evidence suggests that L‐DOPA itself is a neurotransmitter. We here show that L‐DOPA potentiates DA D2 receptor (DRD2) signaling through GPR143, the gene product of X‐linked ocular albinism 1, a G‐protein‐coupled receptor for L‐DOPA. In Gpr143 ‐gene‐deficient ( Gpr143 −/y ) mice, quinpirole, a DRD2/DRD3 agonist, ‐induced hypolocomotion was attenuated compared to wild‐type ( WT ) mice. Administration of non‐effective dose of L‐DOPA methyl ester augmented the quinpirole‐induced hypolocomotion in WT mice but not in Gpr143 −/y mice. In cells co‐expressing GPR143 and DRD2, L‐DOPA enhanced the interaction between GPR143 and DRD2 and augmented quinpirole‐induced decrease in cAMP levels. This augmentation by L‐DOPA was not observed in cells co‐expressing GPR143 and DRD1 or DRD3. Chimeric analysis in which the domain of GPR143 was replaced with GPR37 revealed that GPR143 interacted with DRD2 at the fifth transmembrane domain. Intracerebroventricular administration of a peptide that disrupted the interaction mitigated quinpirole‐induced behavioral changes in WT mice but not in Gpr143 −/y mice. These findings provide evidence that coupling between GPR143 and DRD2 is required for selective DRD2 modulation by L‐DOPA in the dorsal striatum. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevodopaParkinson DiseaseReceptors, Dopamine D2AnimalsMiceCorpus StriatumDopamineQuinpiroleReceptors, Dopamine D1Receptors, G-Protein-CoupledEye ProteinsMembrane Glycoproteins

Stichwörter der Autor:innen

4-dihydroxyphenylalanineDopamine D2 receptorGPCRGPR143L-3dopaminestriatum

Substanzen

DopamineLevodopaQuinpiroleReceptors, Dopamine D1Receptors, Dopamine D2Receptors, G-Protein-CoupledGpr37 protein, mouseGpr143 protein, mouseEye ProteinsMembrane Glycoproteins

Autor:innen und Institutionen

  • Department of Molecular Pharmacology and Neurobiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Department of Physiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Section of Viral Vector Development, Center for Genetic Analysis of Behavior, National Institute for Physiological Sciences, Okazaki, Japan.

ORCID-Profile: Daiki Masukawa, Yoshio Goshima

Förderung

  • Japan Agency for Medical Research and Development
  • Takeda Science Foundation
  • Uehara Memorial Foundation

Zitieren

APA

Masukawa, D., Kitamura, S., Tajika, R., Uchimura, H., Arai, M., Takada, Y., Arisawa, T., Otaki, M., Kanai, K., Kobayashi, K., Miyazaki, T., & Goshima, Y. (2023). Coupling between GPR143 and dopamine D2 receptor is required for selective potentiation of dopamine D2 receptor function by L‐3,4‐dihydroxyphenylalanine in the dorsal striatum. Journal of Neurochemistry, 165(2), 177-195. https://doi.org/10.1111/jnc.15789

Vancouver

Masukawa D, Kitamura S, Tajika R, Uchimura H, Arai M, Takada Y, et al. Coupling between GPR143 and dopamine D2 receptor is required for selective potentiation of dopamine D2 receptor function by L‐3,4‐dihydroxyphenylalanine in the dorsal striatum. Journal of Neurochemistry. 2023;165(2):177-195. doi:10.1111/jnc.15789

BibTeX
@article{Masukawa2023,
  author = {Masukawa, Daiki and Kitamura, Satoshi and Tajika, Rei and Uchimura, Hiraku and Arai, Masami and Takada, Yuuki and Arisawa, Tetsu and Otaki, Momoyo and Kanai, Kaori and Kobayashi, Kenta and Miyazaki, Tomoyuki and Goshima, Yoshio},
  title = {Coupling between GPR143 and dopamine D2 receptor is required for selective potentiation of dopamine D2 receptor function by L‐3,4‐dihydroxyphenylalanine in the dorsal striatum},
  journal = {Journal of Neurochemistry},
  year = {2023},
  volume = {165},
  number = {2},
  pages = {177--195},
  doi = {10.1111/jnc.15789}
}
Kostenlos starten →